Searched for
DRUG PATENT APPLICATIONS
In 1859, Robert Chesebrough saw oil workers scraping sticky rod wax from drilling rigs, and it wasn’t just waste: It became VaselineA chemist named Robert Chesebrough discovered petroleum jelly in the 1800s. He saw value in a sticky wax that oil workers discarded. Cheseb...- AbbVie loses patent plea for Hep C drugThe Indian Patent Office has denied a secondary patent for AbbVie's Hepatitis C drug Maviret. This decision ensures continued access to aff...
- Profit on paper, loss in reality: How a routine accounting tool is used to deceive and take investors for a rideAmortisation is a number most investors skip, but it can shape reported profit. On the surface, it looks routine: A company spreads the cos...
- US raises concerns at India’s duties on IP-intensive goods, source code, AI working paperThe US has voiced concerns over India's high customs duties on IP-intensive products and its proposed mandatory blanket license for AI deve...
- Moderna stocks: MRNA shares jump in US Stock market today after pharma giant surpasses Wall Street estimatesModerna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- Novartis case: Delhi HC pulls up patent office over decade-long delay in breast cancer drug approvalThe Delhi High Court has stepped in with a firm hand, criticizing the patent office for its sluggish response to Novartis AG's 2011 patent ...
- Activists sound alarm bells as Gilead seeks rights over HIV drugLenacapavir, a very expensive drug, is not available in India and many other countries. If the Indian Patent Office clears Gilead's patent ...
- Johnson & Johnson tuberculosis drug's final patent hearing set for todayThe latest secondary patent application, if granted, allows J&J to extend the monopoly on the drug used for treatment of drug resistant (DR...
- India rejects Abbot lab's patent application for HIV drugIndia has rejected a drug patent application of a US multi-national pharma company, paving way for easy access to an important life-saving ...
- Pharma cos lose out in patent office-judiciary stand-offFOR the patent office, the past three years have been like the past three overs of a Twenty20 match.
- Pharma group to oppose patent claimsA group of Indian pharmaceutical firms will collectively oppose as many as 90 drug patent applications sought by global drugmakers and some...
- Indian drugmakers gear up to challenge frivolous MNC patentsLeading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by multinationals in India under the...
- New Delhi rejects American firm's plea to patent Hepatitis B drugThe Delhi Patent Office has rejected American company Gilead Sciences’ plea to patent its Hepatitis B drug adefovir dipivoxil sold under th...
- Now, generic drug cos pop patent pillGeneric drug companies too have joined the rush to seek patents for drugs in India.
- Most Indian drug majors too in line for patent protectionOut of the 8,000 drug patent applications in India filed between 1995 and 2004, about 40% are from Indian pharma companies.
- GSK drops claims on two AIDS medicinesIn a relief to around 2.5 million HIV patients and generic firms like Cipla and Ranbaxy, GlaxosmithKline (GSK) has pulled out the patent ap...
- Wockhardt moves HC for patent lawThe case will reopen the debate on value of incremental innovation as cos seek clarity on patent law.
- It’s patent vs patient in AIDS fightThe battle lines between Western pharmaceutical transnationals and NGOs and patients’ associations are now drawn sharper than ever before. ...
- Local pharma strikes first in patent warGlobal innovator pharma companies and domestic generic players are sparring with each other in the wake of India’s new product patent regim...
Load More
